LB Pharmaceuticals’ Executives Double Down: CMO and CFO Each Exercise 200,000 Stock Options Amid Investor Optimism and Regulatory Anticipation.
LB Pharmaceuticals’ CMO and CFO exercise 200k shares, signaling insider confidence as the company heads toward key regulatory milestones.
3 minutes to read